Schedule 13D ownership disclosure
Clementia Pharmaceuticals Inc.
Security class unavailable · CUSIP: 185575107
Event date: 2017-08-21
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 10,425,225
- Percent of class
- 32.8700%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000947871-17-000667
- Form type
- SC 13D
- Filer
- Clementia Pharmaceuticals Inc.
- CIK
- CIK 1647320
- Filed
- Aug 23, 2017
- Reporting period
- Aug 21, 2017
- Description
- Schedule 13D beneficial ownership